The EOEIAP aims to develop and maintain resources that support ÎÚÑ»´«Ã½ providers to provide high quality care to their patients. The following documents are provided to be used directly or adapted for local use.
Patient Information Leaflet: Immunoglobulin Treatment.
This PIL is intended to be used regionally to support consent to treatment including compliance with SABTO recommendations and the Data Protection Act.
Support for patients receiving immunoglobulin therapy at home
The following patient information leaflet has been designed to provide useful information on the storage of immunoglobulin at home for people self-administering immunoglobulin.
Other patient information leaflets
Immunodeficiency UK produce a leaflet to support patients who are considered for a switch in immunoglobulin product.
The ÎÚÑ»´«Ã½ Immunoglobulin Pharmacy Team have provided a table which may help with questions regarding the storage of particular immunoglobulin medicines.
Immunoglobulin brand information
Further support with implementation of the ÎÚÑ»´«Ã½ Framework for Immunoglobulins (2025)
To support patients during the implementation of the 2025 ÎÚÑ»´«Ã½ Immunoglobulin Framework, the EOEIAP panel has produced this letter which can be used by any ÎÚÑ»´«Ã½ service or hospital in the East of England
To support healthcare professionals during the implementation of the 2025 ÎÚÑ»´«Ã½ Immunoglobulin Framework, the EOEIAP panel has produced this letter which can be used by any ÎÚÑ»´«Ã½ service or hospital in the East of England